Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

CDK5 T724-p
ERK2 S355-p , S358-p , S669-p , S707-p
PKACA S726-p
PKCA S716-p , S726-p
PKCD S726-p
PKCZ S726-p
ROCK1 T445-p , T480-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 S12-p , S355-p
CDK5 T724-p
Chk1 S726-p
ERK2 S355-p , S358-p , S669-p , S707-p
PKACA S59-p , S408-p , S436-p , S481-p , S726-p
PKCA S716-p , S726-p
PKCA S716-p , S726-p
PKCD S726-p
ROCK1 T445-p , T480-p
Regulatory protein:
AMPKA1 S726-p
CD38 S12-p , S358-p , S436-p
CDK5 S726-p
DOCK4 S726-p
EGF S726-p
PKCA S726-p
RHOA S726-p
TBK1 S12-p
Treatment:
angiotensin_2 S12-p , S436-p , S726-p
antibody S726-p
BAPTA-AM S726-p
BIM-X S726-p
bisindolylmaleimide T445-p , S726-p
C3_toxin S726-p
calyculin_A S726-p
cisplatin S726-p
colforsin S716-p , S726-p
dasatinib S358-p , S586-p
EGF S12-p , T724-p
ephrin_B1 Y550-p
fluid_shear_stress T445-p
gefitinib Y550-p , S726-p
GF109203X S726-p
H-89 S726-p
HGF T445-p
high_cell_density S716-p , S726-p
hypercapnia S726-p
ionomycin T445-p
ischemia S586-p , T724-p , S726-p
LPA T445-p , S726-p
LPS S481-p
LRRK2-IN-1 S358-p , S600-p
metastatic potential S358-p
nocodazole S12-p , S465-p , T724-p , S726-p
PAR1-activating_peptide S726-p
peptide inhibitor S726-p
phorbol_ester T445-p , S716-p , S726-p
pleiotrophin S726-p
PV-IgG S726-p
rottlerin S726-p
SB202190 S726-p
SII_angiotensin_2 S431-p , S436-p , S726-p
siRNA T724-p , S726-p
thrombin T445-p , S481-p
TNF S481-p
TRAP S726-p
TxA2 T445-p , S726-p
U0126 S355-p , S358-p , S669-p , S707-p
Y27632 T445-p , S726-p
Z-VAD-FMK S726-p